img
Royal Jelly Modulates Oxidative Stress and Apoptosis in Liver and Kidneys of Rats Treated with Cisplatin    
Yazarlar
Ali Karadeniz
Balıkesir Üniversitesi, Türkiye
Nejdet Şimşek
Balıkesir Üniversitesi, Türkiye
Emre Karakuş
Atatürk Üniversitesi, Türkiye
Serap Yıldırım
Atatürk Üniversitesi, Türkiye
Adem Kara
Atatürk Üniversitesi, Türkiye
Doç. Dr. İsmail CAN Doç. Dr. İsmail CAN
Kafkas Üniversitesi, Türkiye
Fikrullah Kısa
Türkiye
Habib Emre
Yüzüncü Yıl Üniversitesi, Türkiye
Mehmet Türkeli
Atatürk Üniversitesi, Türkiye
Özet
Cisplatin (CDDP) is one of the most active cytotoxic agents in the treatment of cancer and has adverse side effects such as nephrotoxicity and hepatotoxicity. The present study was designed to determine the effects of royal jelly (RJ) against oxidative stress caused by CDDP injury of the kidneys and liver, by measuring tissue biochemical and antioxidant parameters and investigating apoptosis immunohistochemically. Twenty-four Sprague Dawley rats were divided into four groups, group C: control group received 0.9% saline; group CDDP: injected i.p. with cisplatin (CDDP, 7 mg kg(-1) body weight i.p., single dose); group RJ: treated for 15 consecutive days by gavage with RJ (300 mg/kg/day); group RJ + CDDP: treated by gavage with RJ 15 days following a single injection of CDDP. Malondialdehyde (MDA) and glutathione (GSH) levels, glutathione S-transferase (GST), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) activities were determined in liver and kidney homogenates, and the liver and kidney were also histologically examined. RJ elicited a significant protective effect towards liver and kidney by decreasing the level of lipid peroxidation (MDA), elevating the level of GSH, and increasing the activities of GST, GSH-Px, and SOD. In the immunohistochemical examinations were observed significantly enhanced apoptotic cell numbers and degenerative changes by cisplatin, but these histological changes were lower in the liver and kidney tissues of RJ + CDDP group. Besides, treatment with RJ lead to an increase in antiapoptotic activity hepatocytes and tubular epithelium. In conclusion, RJ may be used in combination with cisplatin in chemotherapy to improve cisplatin-induced oxidative stress parameters and apoptotic activity.
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
Dergi ISSN 1942-0900
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 01-2011
Cilt No 2011
Sayfalar 1 / 10
Doi Numarası 10.1155/2011/981793
Makale Linki http://www.hindawi.com/journals/omcl/2011/981793/